Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Author: admin
In the quest for better health, weight loss, and stable energy, fruit often finds itself in the crosshairs of nutritional debate. “Is fruit too high in sugar?” “Can I eat bananas if I have diabetes?” These are common questions. The answer lies not just in the sugar content, but in how that food affects your blood sugar levels. This is where low glycemic fruits become your most powerful dietary ally. What Are Low Glycemic Fruits? So, what are the low glycemic fruits? Simply put, these are fruits that rank low on the Glycemic Index (GI), a system that ranks foods…
In a New York operating room one day in October 2025, doctors made medical history by transplanting a genetically modified pig kidney into a living patient as part of a clinical trial. The kidney had been engineered to mimic human tissue and was grown in a pig, as an alternative to waiting around for a human organ donor who might never come. For decades, this idea lived at the edge of science fiction. Now it’s on the table, literally.The patient is one of six taking part in the first clinical trial of pig-to-human kidney transplants. The goal: to see whether…
Bets on automation underscore investor confidence in industrializing cell therapies as patient demand continues to outpace supply. Cellular Origins, a Cambridge, UK–based manufacturing automation company, has closed a $40 million over-subscribed Series A financing round, marking a significant step toward industrializing the production of cell therapies. The round was led by Johnson & Johnson, through its corporate venture capital arm, Johnson & Johnson Innovation – JJDC, Inc, with participation from Highland Europe, BGF, NYBC Ventures and TTP Group. The funding comes as cell therapies, often described as one of the most transformative advances in modern medicine, continue to face a…
1995: Establishing the connection to gut health. While dietary oligosaccharides have a long history of use for health promotion, particularly in Asia, it was not until 1995 that Glenn Gibson and Marcel Roberfroid expanded the definition of the prebiotic concept with: “nondigestible food ingredients that beneficially affect the host by selectively stimulating the growth and/or activity of one or a limited number of bacterial species already resident in the colon, and thus attempt to improve host health”. The criteria for classifying a substance as a prebiotic were largely constrained by the microbiological tools available at the time. A substance had…
Credit: SergeyNivens/Getty Images An artificial intelligence (AI) model developed by researchers at the University of Michigan and Invia Medical Imaging Solutions can help diagnose a relatively common but underdiagnosed heart condition using a simple electrocardiogram (ECG). In a recent study, the researchers showed that using a self-supervised artificial intelligence model they could accurately diagnose coronary microvascular dysfunction. This condition impacts the very small blood vessels in the heart that fail to dilate or regulate blood flow properly, causing ischemia even when the large coronary arteries appear to be normal. “Our model creates a way for clinicians to accurately identify a…
Trained in medicine and public health, this postdoc studies how social and structural factors shape HIV prevention outcomes.Image credit:Fluence Photography, ©iStock.com, CIPhotosQ | Write a brief introduction to yourself including the lab you work in and your research background. My name is Isabella Batina. I’m a medical doctor from Mexico City with a master’s in public health from Emory University. I currently work as a postdoctoral research fellow at the Ponce Clinical Research Site in Atlanta, where I contribute to clinical trials related to HIV prevention and PrEP care delivery.Q | How did you first get interested in science and/or…
Phase III trial shows up to 28.7% weight loss, but tolerability remains a key concern for Eli Lilly’s triple-agonist therapy. Major American global pharmaceutical company Eli Lilly’s experimental obesity therapy, retatrutide, has surpassed expectations in its Phase 3 TRIUMPH-4 trial, producing an average weight loss of 28.7% among participants who completed 68 weeks of treatment. The results suggest retatrutide could redefine standards for metabolic and obesity care, though higher discontinuation rates compared with existing therapies remain a concern [1]. Retatrutide is a first-in-class triple hormone receptor agonist, simultaneously activating GLP-1, GIP and glucagon receptors. This builds on the dual-agonist mechanism…
Doctors diagnose human lungs Is it all gone? For countless cancer patients who have undergone treatment, the question of recurrence may never fully leave. This doubt can jockey away the reins of a patient’s life, dragging them along an endless cycle of waiting, scanning, and hoping. The emotional toll of cancer surveillance cannot be overstated. “Unless you are a physician or a cancer patient, many people do not realize that patients often live under a cloud of uncertainty throughout their entire journey,” Richard Chen, MD, executive vice president of R&D, and chief medical officer, told Inside Precision Medicine. “This uncertainty…
Chai Discovery has completed a $130 million Series B financing that the artificial intelligence (AI)-based de novo antibody designer says will help it accelerate its research and product development, as well as grow its commercialization efforts toward creating the equivalent of a computer-aided design suite for molecules. Chai—a portmanteau for “chemistry” and “AI”—creates de novo antibodies through its Chai-2 platform. The company says Chai-2 is the first zero-shot generative platform to achieve double-digit success rates in experiments focused on de novo antibody design. Chai unveiled Chai-2 in June with a preprint posted in bioRxiv that reported a 16% success rate in…
Let’s face it: Nobody pursues a career in science for the joy of culturing cells. But this thankless and time-intensive task is the backbone of biological research. When it’s done extremely well, the results generated from experiments can open entirely new avenues of scientific pursuit, leading to the development of the best-performing cell therapy candidates and minimizing the need for testing animal models. But how often does our cell culture game live up to that potential?Indeed, one of the most important elements in culturing cells is often overlooked: assessing the influence of the environment on the residing cells and creating…